Fuchs Endothelial Corneal Dystrophy Clinical Trials

30 clinical trials for Fuchs Endothelial Corneal Dystrophy across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prognosis of Posterior Lamellar Keratoplasty — RECRUITING
• Effect of Descemet Membrane Polishing in Fuchs Endothelial Corneal Dystrophy — RECRUITING · NA
• Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years — RECRUITING · NA
• Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK) — RECRUITING · NA
• DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy — RECRUITING · PHASE2
• SUCCESS Score Validation in Fuchs Dystrophy — RECRUITING
• Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy — RECRUITING · PHASE2
• Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts — RECRUITING
• The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy — RECRUITING
• A DOUBLE-MASKED, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, 12-WEEK ADMINISTRATION WITH TWO-WEEK GRADUAL DOSE TAPER PHASE AND 38-WEEK FOLLOW-UP PHASE, PHASE 3 STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RIPASUDIL (K-321) EYE DROPS AFTER DESCEMETORHEXIS IN SUBJECTS WITH FUCHS ENDOTHELIAL CORNEAL DYSTROPHY — RECRUITING · PHASE3
• Postoperative CCT in FECD vs. Non-FECD — NOT_YET_RECRUITING
• A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) — COMPLETED · PHASE2
• A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) — COMPLETED · PHASE3
• Partial Range Of Field IOLs in DMEK-Enabled Procedures — NOT_YET_RECRUITING · NA
• Assessment of Corneal Endothelial Function Following Hypoxic Stress — WITHDRAWN · PHASE1
• A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) — COMPLETED · PHASE3
• Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients. — COMPLETED
• A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehicle in Subjects with Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM Study — OTHER · PHASE2
• A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects with Fuchs Endothelial Corneal Dystrophy — OTHER · PHASE3
• Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema — COMPLETED · PHASE1
• Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis — COMPLETED · PHASE2
• A Phase 1/ Phase 2 Study of TTHX1114(NM141) — COMPLETED · PHASE1
• A DOUBLE-MASKED, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, 12-WEEK ADMINISTRATION WITH TWO-WEEK GRADUAL DOSE TAPER PHASE AND 38-WEEK FOLLOW-UP PHASE, PHASE 3 STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RIPASUDIL (K-321) EYE DROPS AFTER SIMULTANEOUS CATARACT SURGERY AND DESCEMETORHEXIS IN SUBJECTS WITH FUCHS ENDOTHELIAL CORNEAL DYSTROPHY — COMPLETED · PHASE3
• Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France. — COMPLETED
• Predictive Factors of Graft Detachment Following Dmek — COMPLETED
• Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3 — WITHDRAWN · PHASE1
• The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK — OTHER
• Study of Endothelial Keratoplasty Outcomes — COMPLETED · NA
• Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology — COMPLETED · NA
• Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) — OTHER · NA

Refine this search